BRCA2 and ovarian cancer: The 70 non-BRCA1/2 patients included in the study originated from 58 breast and/or ovarian cancer families tested negative for germline mutations in BRCA1 or BRCA2. From 10 of these families, breast tumor biopsies were available from two affected family members and from a single family we obtained tumor material from three patients.